Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is publicly listed on the Shenzhen Stock Exchange, trading under the official stock code 300357. Operating as a specialized modern biopharmaceutical enterprise dedicated to the research, development, and commercial distribution of allergen immunotherapy products and diagnostic treatments, its shares are actively traded on the ChiNext board.